Manufacturing

Can Potato Peptides Reduce Serum Needs in Cell Culture?
Management & Regulatory Can Potato Peptides Reduce Serum Needs in Cell Culture?

Establishing mathematical models for population growth highlights how plant-based supplements can match the theoretical carrying capacity of full-serum media. As we navigate the bioprocessing landscape of 2026, the reliance on animal-derived components like fetal bovine serum and newborn calf serum

Strengthening Biosafety With a Human Capital Framework
Management & Regulatory Strengthening Biosafety With a Human Capital Framework

Practical experiments in ethics-integrated education are essential for developing a workforce capable of navigating the moral complexities of modern genetic engineering. As synthetic biology moves from the theoretical confines of academic research into the rapid-fire pace of industrial

Study Links MAGE-A4 Levels and Tumor Burden to Afami-Cel Success
Research & Development Study Links MAGE-A4 Levels and Tumor Burden to Afami-Cel Success

The biological hurdles of treating solid tumors with T-cell therapy are being decoded through new findings linking tumor lesion diameters to the ultimate durability of the patient response. At the current Society for Immunotherapy of Cancer Annual Meeting, researchers presented updated data

SynFit AI Tool Streamlines Complex Enzyme Engineering
Biotech & Bioprocessing SynFit AI Tool Streamlines Complex Enzyme Engineering

The complexity of molecular transformations in pharmaceutical synthesis demands enzymes that maintain high selectivity without sacrificing the speed of the chemical reaction. These biological catalysts are the foundation of many life-sustaining processes, yet their natural forms are rarely suited

Will Tougher Quality Rules Transform India's Pharma Sector?
Management & Regulatory Will Tougher Quality Rules Transform India's Pharma Sector?

The global medical supply chain relies heavily on Indian manufacturing, making any shift in domestic pharmaceutical regulations a matter of international concern for healthcare providers and patients alike. The Ministry of Health recently proposed rigorous amendments to the Drugs Rules, signaling a

How Will Lonza’s U.S. Expansion Reshape the CDMO Market?
Management & Regulatory How Will Lonza’s U.S. Expansion Reshape the CDMO Market?

The Carlsbad facility brings end-to-end viral vector solutions and aseptic fill-finish capabilities to Lonza, catering specifically to the burgeoning cell and gene therapy market. This strategic acquisition of five specialized contract development and manufacturing organization (CDMO) sites from

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later